Science Explorer Back to mapMap
Discussion
Researcher · Hospital Israelita Albert Einstein · Brazil

Marcelo Campos Vieira

Marcelo Campos Vieira publishes mostly in Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology, on topics such as Amyloidosis: Diagnosis, Treatment, Outcomes, Cardiac Valve Diseases and Treatments and Infective Endocarditis Diagnosis and Management.

OpenAlex
World rank
#6,410,742
of 7,710,434 ranked researchers
Rank in Brazil
#171,578
of 253,246
Works
15
Citations
32
Citations per work
2.1
h-index
4
i10-index 1Top 90% in Cardiology and Cardiovascular Medicine
Marcelo Campos Vieira

What does Marcelo Campos Vieira research?

Marcelo Campos Vieira's work is mostly in Medicine (36%), Biochemistry, Genetics and Molecular Biology (10%), Engineering (5%).

Everything else: 7 works · 48.7% of their workHealth Sciences: 5 works · 35.9% of their workMedicine: 5 works · 35.9% of their workCardiology and Cardiovascular Medicine: 2 works · 15.4% of their workEpidemiology: 1 works · 7.7% of their workRheumatology: 1 works · 7.7% of their workNeurology: 1 works · 5.1% of their workLife Sciences: 2 works · 10.3% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 10.3% of their workMolecular Biology: 2 works · 10.3% of their workPhysical Sciences: 1 works · 5.1% of their workEngineering: 1 works · 5.1% of their workBiomedical Engineering: 1 works · 5.1% of their workTHEIR WORKMarcelo CamposVieira15works
Life Sciences10%Physical Sciences5%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else748.7%
    1. Medicine535.9%
    1. Biochemistry, Genetics and Molecular Biology210.3%
    1. Engineering15.1%
  1. 1Cardiology and Cardiovascular Medicine15% of their works
  2. 2Molecular Biology10% of their works
  3. 3Epidemiology8% of their works
  4. 4Rheumatology8% of their works
  5. 5Neurology5% of their works
  6. 6Biomedical Engineering5% of their works

Research topics

Which keywords describe Marcelo Campos Vieira's research?

The keywords of their largest research topics: Diagnosis, Treatment, Cardiac Amyloidosis, Transthyretin, Cost-effectiveness Analysis, Epidemiology, FGF23 and Infective Endocarditis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Diagnosis62 topics
  2. Treatment62 topics
  3. Cardiac Amyloidosis41 topic
  4. Transthyretin41 topic
  5. Cost-effectiveness Analysis21 topic
  6. Epidemiology21 topic
  7. FGF2321 topic
  8. Infective Endocarditis21 topic
  9. Inflammation21 topic
  10. Quality of Life21 topic
  11. Rheumatoid Arthritis21 topic
  12. Surgical Aortic-Valve Replacement21 topic
  13. Transcatheter Aortic-Valve Replacement21 topic
  14. phosphate21 topic
  15. Arterial Calcification11 topic
  16. Extracorporeal Membrane Oxygenation11 topic
  17. Left Ventricular Assist Device11 topic
  18. Pseudoxanthoma Elasticum11 topic

Where does Marcelo Campos Vieira work?

Marcelo Campos Vieira's main affiliation in the publication record is Hospital Israelita Albert Einstein, Brazil.

How many publications and citations does Marcelo Campos Vieira have?

OpenAlex counts 15 works and 32 citations for Marcelo Campos Vieira, an h-index of 4, ranking #6,410,742 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Marcelo Campos Vieira. Posts are plain text and can be reported.